Zepatier and Back pain - a phase IV clinical study of FDA data

Summary:

Back pain is reported as a side effect among people who take Zepatier (elbasvir; grazoprevir), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Hepatitis c.

The phase IV clinical study analyzes which people have Back pain when taking Zepatier. It is created by eHealthMe based on reports of 4,481 people who have side effects when taking Zepatier from the FDA, and is updated regularly.

What is Zepatier?

Zepatier has active ingredients of elbasvir; grazoprevir. eHealthMe is studying from 4,482 Zepatier users. Check the latest studies of Zepatier.

What is Back pain?

Back pain is found to be associated with 3,217 drugs and 4,710 conditions by eHealthMe. Check the latest studies of Back pain.

On Jul, 14, 2026

4,481 people reported to have side effects when taking Zepatier.
Among them, 44 people (0.98%) have Back pain.

Among these 44 people:

How long have people been on Zepatier when they have Back pain? *

What is the gender of people who have Back pain when taking Zepatier? *

female: 40 %
male: 60 %

What is the age of people who have Back pain when taking Zepatier? *

What are other drugs people take besides Zepatier? *

What are other side effects people have besides Back pain? *

Pain In Extremity: 7 people, 15.91%
Headache (pain in head): 5 people, 11.36%
Neck Pain: 4 people, 9.09%
Fatigue (feeling of tiredness): 4 people, 9.09%
Weakness: 4 people, 9.09%
Nausea (feeling of having an urge to vomit): 4 people, 9.09%
Constipation: 3 people, 6.82%
Abdominal Pain Upper: 3 people, 6.82%
Indigestion: 2 people, 4.55%
Nausea And Vomiting: 2 people, 4.55%

What are the existing conditions these people have? *

Hepatitis C: 32 people, 72.73%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 6.82%
Diabetes: 2 people, 4.55%
Cough: 2 people, 4.55%
Constipation: 2 people, 4.55%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 2.27%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 1 person, 2.27%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 1 person, 2.27%
Multiple Myeloma (cancer of the plasma cells): 1 person, 2.27%
Hepatitis (inflammation of the liver): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Zepatier and have Back pain?

- Check whether Back pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zepatier:

Zepatier (4,482 reports)

Back pain treatments and more:

Back pain (379,875 reports)

Browse all side effects of Zepatier:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain:

Back pain (3,217 drugs)

Browse all the conditions that are associated with Back pain:

Back pain (4,710 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on elbasvir; grazoprevir (the active ingredients of Zepatier) and Zepatier (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.